CONNECT WITH US
HealthTech

HealthTech

Ketamine's role in alleged Cornell rape highlights flood of psychoactive drugs on campus

Medical Xpress logo

Published on

Add as a preferred source on Google
Ketamine's role in alleged Cornell rape highlights flood of psychoactive drugs on campus

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Former Cornell student Jane Doe, who filed a civil lawsuit in September 2026 alleging that seven fraternity members raped her at a party, said the young men who assaulted her pressured her into taking the drug ketamine.

As an emergency room physician, medical toxicologist and the head of student health services at the University of Virginia, I have had a front-row seat to the growing danger that psychoactive substances such as ketamine present to the health and safety of university students.

Ketamine and its emerging spinoff versions are part of a wave of new and evolving designer drugs entering the United States and other countries. How widely these substances are used remains unknown, since most hospitals are unable to detect them on standard urine drug screens. But ketamine and other drugs are being increasingly reported as agents used in sexual assault—either when people take these drugs voluntarily, are pressured to take them or are given them covertly.

The increasing prevalence of ketamine and other drugs—and their use in sexual assault—is playing out on college campuses across the U.S. and putting students at risk.

Ketamine is a synthetic chemical that was first synthesized in 1962. S. Food and Drug Administration approved it as a general anesthetic for people and animals in 1970, and doctors and veterinarians used it for decades to induce anesthesia during surgeries and to relieve pain.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.